KCT0000613
Completed
未知
Comparison of 10-day standard triple therapy and nonbismuth-containing concomitant therapy for Helicobacter pylori eradication in Korea
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Kyungpook National University Medical Center
- Enrollment
- 348
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Either sex in age of 18 to 85
- •2\) Among patients with active/inactive peptic ulcer diagnosed from endoscopy, those who have come up with benign helicobacter after an examination (a rapid urease test)
- •3\) Among patients with no organic disorders from endoscopy but with indigestion, those who have been diagnosed with benign helicobacter after an examination (a rapid urease test) and those who are willing to get a bacteria\-removal treatment
- •4\) Among patients who received endoscopic mucosal resection or submucosal dissection to treat gastric adenoma or early gastric cancer, those with benign helicobacter diagnosed from an examination
- •5\) Those who have signed a written subject consent to join the experimentation
Exclusion Criteria
- •1\) Patients who have refused to participate in the experimentation
- •2\) Patients who have been cured by the helicobacter eradication
- •3\) Patients who have taken drugs for the last two weeks which would affect a bacteria examination and treatment (proton pump inhibitor, antibiotics, H2\-receptor antagonist and bismuth)
- •4\) Patients who are on steroids, aspirin and antithrombotic
- •5\) Patients who have gone through a gastric operation (a gastric mucosal resection excluded)
- •6\) Patients with severe heart disease, lung disease, hormonal disorder
- •7\) Patients with severe problems in kidney and liver
- •8\) Patients with blood disease
- •9\) Patients with cancer
- •10\) Expecting mother or patients with chances to be pregnant
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The effect of taking antibiotic on treatment of Helicobacter pylori infectioCondition 1: Duodenal ulcer. Condition 2: Helicobacter Pylori.erosion (acute) of duodenum, ulcer (peptic): duodenal-postpyloricHelicobacter pylori [H.pylori] as the cause of diseases classified to other chaptersIRCT2015110124823N1Vice chancellor For Research Of Ahvaz Jundishapur University of Medical Sciences168
Completed
Not Applicable
The prospective trial to validate the superior efficacy of sequential therapy to standard therapy in Helicobacter pylori eradicatioDiseases of the digestive systemKCT0000014Daegu-Kyungpook Gastrointestinal Study Group348
Recruiting
Phase 4
A clinical trial to compare the efficacy of 7-day and 14-day triple drug therapy for the eradication treatment of Helicobacter pylori infectioHealth Condition 1: null- Patients with symptomatic Helicobacter pylori infectionCTRI/2011/11/002139Pradeep Kumar P320
Not yet recruiting
Phase 3
Comparison of two antibiotic regimens in eradicating Helicobacter pyloriHelicobacter pylori infection.Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhereB96.81IRCT20210209050313N1Tehran University of Medical Sciences130
Recruiting
Phase 3
Comparative evaluation of triple therapy with high dose amoxicillin versus bismuth-based therapy in second-line therapy for eradication of helicobacter pylori infection in childreH.pylori Gastritis.Helicobacter pylori [H.pylori] as the cause of diseases classified to other chaptersB98.0IRCT20191022045195N1Qazvin University of Medical Sciences50